Derebail publishes article that may explain different treatment needs for African American dialysis patients
March 11, 2015
Vimal K. Derebail, MD, MPH, has authored a study, “Variant hemoglobin phenotypes may account for differential erythropoietin-stimulating agent dosing in African-American hemodialysis patients” published on-line on August 17 in Kidney International. In this study, Dr. Derebail and his colleagues evaluated the influence of abnormal hemoglobin variants including sickle cell trait...